Skip to main content Accessibility help
×
Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-30T20:11:35.659Z Has data issue: false hasContentIssue false

1.13 - Approaches to Behavioral Disturbances in Dementia and Traumatic Brain Injury Patients

from Part I - Treatment Strategies

Published online by Cambridge University Press:  19 October 2021

Michael Cummings
Affiliation:
University of California, Los Angeles
Stephen Stahl
Affiliation:
University of California, San Diego
Get access

Summary

Of the many behavioral disturbances associated with severe mental and neurocognitive disorders, impulsive behaviors, including agitation and aggression, present unique challenges. Frontal inhibition, cognitive impairments, and executive dysfunction commonly combine to promote behavioral disturbances in severe mental and neurocognitive disorders, and the interplay between structures and circuits may explain a mechanism for the impulsive behaviors, agitation, and aggression. A circuit of periaqueductal gray matter, hippocampus, amygdala, and hypothalamus mediates threat response, a bottom-up impulse. Prefrontal cortex (PFC) serves a top-down role to inhibit those bottom-up impulses, and PFC dysfunction impairs a person’s ability to recognize social cues and increases the risk of impulsive aggressive responses by a person failing to make appropriate risk/reward assessments for inhibiting responses. Added sensory deficits in hearing, vision, or pain together with sensory processing and appraisal deficits in cognition combine to foster behavioral disturbances of agitation, aggression, and impulsive acts [1]. Of the PFC, specifically the ventromedial PFC and its connections to lower structures, such as the amygdala, serve this top-down inhibitory function [1, 2]. PFC-amygdala circuit connectivity is disrupted by dysfunction in associated serotonin and dopamine systems in several mental conditions. Enhancing serotonergic and dopaminergic signaling in and around this circuit provides a theoretical approach to pharmacologic agent selection for many of these behavioral disturbances. Severe mental and neurocognitive disorders, including traumatic brain injury (TBI), often show pathology in the brain regions associated with top-down and bottom-up structures, as described above [3].

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Siever, L. J. (2008). Neurobiology of aggression and violence. Am J Psychiatry, 165, 429442.CrossRefGoogle ScholarPubMed
Meyer, J. M., Cummings, M. A., Proctor, G., et al. (2016). Psychopharmacology of persistent violence and aggression. Psychiatr Clin North Am, 39, 541556.Google Scholar
Rosenbloom, M. H., Schmahmann, J. D., Price, B. H. (2012). The functional neuroanatomy of decision-making. J Neuropsychiatry Clin Neurosci, 24, 266277.Google Scholar
Nash, R. P., Weinberg, M. S., Laughon, S. L., et al. (2019). Acute pharmacological management of behavioral and emotional dysregulation following a traumatic brain injury: a systematic review of the literature. Psychosomatics, 60, 139152.Google Scholar
Hicks, A. J., Clay, F. J., Hopwood, M., et al. (2019). The efficacy and harms of pharmacological interventions for aggression after traumatic brain injury: a systematic review. Front Neurol, 10, 1169.Google Scholar
Tangamornsuksan, W., Chaiyakunapruk, N., Somkrua, R., et al. (2013). Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol, 149, 10251032.Google Scholar
Hammond, F. M., Bickett, A. K., Norton, J. H., et al. (2014). Effectiveness of amantadine hydrochloride in the reduction of chronic traumatic brain injury irritability and aggression. J Head Trauma Rehabil, 29, 391399.CrossRefGoogle ScholarPubMed
Sami, M. B., Faruqui, R. (2015). The effectiveness of dopamine agonists for treatment of neuropsychiatric symptoms post brain injury and stroke. Acta Neuropsychiatr, 27, 317326.Google Scholar
Hammond, F. M., Malec, J. F., Zafonte, R. D., et al. (2017). Potential impact of amantadine on aggression in chronic traumatic brain injury. J Head Trauma Rehabil, 32, 308318.Google Scholar
Hammond, F. M., Sherer, M., Malec, J. F., et al. (2015). Amantadine effect on perceptions of irritability after traumatic brain injury: results of the amantadine irritability multisite study. J Neurotrauma, 32, 12301238.Google Scholar
Cummings, J., Lai, T. J., Hemrungrojn, S., et al. (2016). Role of donepezil in the management of neuropsychiatric symptoms in Alzheimer’s disease and dementia with Lewy bodies. CNS Neurosci Ther, 22, 159166.CrossRefGoogle ScholarPubMed
Gareri, P., Putignano, D., Castagna, A., et al. (2014). Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer’s disease: the MEMAGE study. J Alzheimers Dis, 41, 633640.Google Scholar
Seitz, D. P., Adunuri, N., Gill, S. S., et al. (2011). Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev, 2011, CD008191.Google Scholar
Maust, D. T., Kim, H. M., Seyfried, L. S., et al. (2015). Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry, 72, 438445.Google Scholar
Deardorff, W. J., Grossberg, G. T. (2019). Behavioral and psychological symptoms in Alzheimer’s dementia and vascular dementia. Handb Clin Neurol, 165, 532.Google Scholar
Reus, V. I., Fochtmann, L. J., Eyler, A. E., et al. (2016). The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. Am J Psychiatry, 173, 543546.Google Scholar
Devanand, D. P., Mintzer, J., Schultz, S., et al. (2012). The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design. Am J Geriatr Psychiatry, 20, 362373.Google Scholar
Gallagher, D., Herrmann, N. (2014). Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy? Drugs, 74, 17471755.Google Scholar
Suzuki, H., Gen, K. (2015). Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in Alzheimer’s disease with behavioural and psychological symptoms of dementia: a preliminary open-label trial. Psychogeriatrics, 15, 3237.Google Scholar
Tampi, R. R., Tampi, D. J. (2014). Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials. Am J Alzheimers Dis Other Demen, 29, 565574.Google Scholar
Plantier, D., Luaute, J., Group, S. (2016). Drugs for behavior disorders after traumatic brain injury: systematic review and expert consensus leading to French recommendations for good practice. Ann Phys Rehabil Med, 59, 4257.CrossRefGoogle ScholarPubMed
Keszycki, R. M., Fisher, D. W., Dong, H. (2019). The hyperactivity-impulsivity-irritiability-disinhibition-aggression-agitation domain in Alzheimer’s disease: current management and future directions. Front Pharmacol, 10, 1109.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×